MYPROTOCOLSTACK
PeptidesBiomarkersCalculatorsBlogStart tracking →
BIOMARKER LIBRARY

Biomarker Profiles

Reference vs optimal ranges for the biomarkers most commonly tracked on peptide, GLP-1, and optimization protocols. Each guide covers what the marker measures, what moves it, and which compounds reliably change it.

GROWTH
IGF-1
Insulin-like Growth Factor 1
The primary downstream mediator of growth hormone, and the main lab marker used to monitor GH secretagogue protocols.
Optimal: Upper quartile for age — typically 180–240 ng/mL for ages 30–50
CARDIOVASCULAR
ApoB
Apolipoprotein B
The single most accurate serum marker of atherosclerotic cardiovascular risk — more predictive than LDL-C.
Optimal: <80 mg/dL (general population); <60 mg/dL (existing CVD or high risk)
HORMONE
Total Testosterone
Total Testosterone
The most commonly measured hormone in men — but rarely the most informative without the context of SHBG and free testosterone.
Optimal: 500–900 ng/dL is a common target in optimization practice
Estradiol
Estradiol (E2) — Sensitive Assay
The primary estrogen in both sexes. In men, tight tracking matters on testosterone-modulating protocols to catch both excess and deficiency.
Optimal: Men: 20–35 pg/mL on TRT; premenopausal women: phase-dependent
METABOLIC
HbA1c
Glycated Hemoglobin (A1C)
Reflects average blood glucose over the prior ~90 days — the gold-standard measure of chronic glycemic control.
Optimal: <5.4% (metabolic optimization target)
INFLAMMATION
hs-CRP
High-Sensitivity C-Reactive Protein
The most commonly used marker of low-grade systemic inflammation and cardiovascular risk.
Optimal: <1.0 mg/L — often <0.5 mg/L in highly optimized individuals
Track all of them in one place.

Upload any lab PDF — MyProtocolStack auto-extracts values and maps them to 40+ tracked biomarkers. StackAI reads the panel in context of your protocol.

Start tracking →

Informational only — not medical advice. Reference ranges vary by lab and individual context. Work with a licensed provider to interpret your specific results.